Jordan Altman is an intellectual property transactions partner based in Ropes & Gray’s New York office. He leads transformative, business-critical transactions that focus on intellectual property and technology and span a wide range of industries, including fintech, financial services, consumer products, telecommunications, entertainment, sports, energy, life sciences, chemicals, medical devices, air and space, and industrials. Jordan has deep experience advising on intellectual property and technology licensing agreements, mergers and acquisitions, strategic alliances, joint ventures, distribution agreements, and other commercial agreements. Clients look to Jordan as a leader in such technology sectors as big data, artificial intelligence, software and telecommunications. 

Jordan has experience with all facets of intellectual property, including patents, trademarks, copyrights, and trade secrets, and regularly advises clients on intellectual property portfolio development. He spent his early career as a patent examiner and is a registered patent agent with the U.S. Patent and Trademark Office. 

Prior to joining Ropes & Gray, Jordan was a partner in the New York office of another international law firm.

Experience

Licensing, Collaborations and Technology Transactions

  • Torchlight Investors LLC in connection with a multiplatform outsourcing agreement.*
  • InnovaHeart SRL in an exclusive licensing agreement with Grand Pharmaceutical Group Limited for a transcatheter mitral valve replacement system.*
  • Venner Medical in connection with agreements for the development and testing of medical devices.*
  • LMA North America, Inc. in connection with a global supply and distribution agreement relating to medical devices.*
  • The Laryngeal Mask Company in connection with technology and patent license agreements for medical devices.*
  • Inspirna, Inc. in its clinical collaboration with Bristol Myers Squibb regarding a lead product candidate.*
  • Genmab A/S in connection with various technology license and commercialization agreements for a pharmaceutical compound and with its initial public offering and listing on the Nasdaq.*
  • Various agreements for funding the clinical development of therapeutic compounds belonging to Dynavax Technologies Corp. and Ionis Pharmaceuticals.*

Mergers, Acquisitions, Joint Ventures and Private Equity Transactions

  • Nippon Steel Corporation (NSC), Japan’s largest steelmaker, in a definitive agreement to acquire U.S. Steel in an all-cash transaction at $55.00 per share, representing an equity value of approximately $14.1 billion plus the assumption of debt, for a total enterprise value of $14.9 billion.
  • Aquiline Capital Partners LP, a private investment firm investing in financial services and related technologies with over $10 billion in assets under management, in numerous transactions, including:
    • in its majority investment in Pharma Force Group LLC, a pharmacy solutions provider to hospitals and health clinics.
    • in its investment in Health Prime International, a provider of revenue cycle management solutions for physician practices.
    • in the formation of MDpanel, a platform aimed at improving the processing of workers’ compensation insurance claims.
  • REV Group, Inc., a manufacturer of industry-leading specialty vehicle brands, in the sale of its school bus business, Collins Bus Corporation, to Forest River Bus, LLC, a Berkshire Hathaway company, for a purchase price of $303.0 million in cash.
  • Avista Capital Partners, a leading healthcare-focused private equity firm, on its acquisition of Terrats Medical, a leading global provider of dental prosthetics, including abutments and implants, from Miura Partners.
  • Atria Wealth Solutions, Inc., a wealth management solutions holding company and portfolio company of Lee Equity Partners, in a definitive purchase agreement to be sold to LPL Financial Holdings Inc.
  • VettaFi, a portfolio company of Aretex Capital Partners, in its sale to TMX Group. TMX Group agreed to acquire the remaining approximately 78% of the common units of VettaFi for approximately $848 million, after investing in a 22% stake in VettaFi earlier this year.
  • Lee Equity Partners, LLC in the acquisition of Carisk® Partners, a specialty risk transfer and care coordination company serving insurers, government entities, self-insured plan sponsors and other managed care organizations.
  • AEA Investors and its portfolio company Process Sensing Technologies (PST) in PST’s acquisition of Fluid Components International (FCI). Financial terms were not disclosed.
  • Morgan Stanley Tactical Value in its partnership with Kobalt Partners to invest more than $700 million to acquire music copyrights over the next few years.
  • CCMP Growth Advisors in its investment in Decks & Docks, the largest specialty distributor of marine construction and outdoor living supplies in the Eastern United States.
  • Kohlberg & Company in its acquisition of Riveron, including IP- and data privacy- focused due diligence on the company and drafting and negotiating multiple provisions in the Purchase Agreement.
  • TPG in its agreement to acquire Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, from Thomas H. Lee Partners for $1.4 billion including IP-focused due diligence and drafted and negotiated multiple terms in the Purchase Agreement.
  • New Mountain Capital and its portfolio company HealthComp, a benefits and analytics platform, in entering into a definitive agreement to combine HealthComp with Virgin Pulse, a leading digital health, wellbeing and navigation company to create the first national value-based care platform company focused on employee health and outcomes.
  • Citrix Systems, Inc. in its $2.25 billion acquisition of Wrike, Inc.*
  • Hitachi, Ltd. in its $9.5 billion acquisition of GlobalLogic Inc.*
  • SS&C Technologies Holdings, Inc. in the $1.45 billion acquisition of Eze Software Group LLC.*
  • Integration Appliance, Inc. in its acquisition of DealCloud, Inc.*
  • Salesforce.com, Inc. in its acquisition of Demandware, Inc. for approximately $2.8 billion.*
  • SunGard Data Systems Inc. in its acquisition by Fidelity National Information Services Inc.*
  • Nokia Corporation in connection with its acquisition of SpaceTime Insight, Inc., and with the contemplated acquisition of Withings.*
  • Texas Instruments in its acquisition of the Lehi, Utah semiconductor manufacturing facility from Micron Technology.*
  • Nokia Corporation in its acquisition of Eta Devices, a company that manufactures advanced radio transmitters.*
  • KMG Chemicals, a producer and distributor of specialty chemicals and performance materials for the semiconductor market, in its $1.6 billion acquisition by Cabot Microelectronics*
  • Liberty Global plc in its acquisition of Cable & Wireless Communications plc.*
  • Viacom in its remerger with CBS – 2020 Most Innovative Deal of the Year Award, The Deal.*
  • Altice N.V. in its acquisition of Cablevision Systems Corporation.*
  • ViacomCBS in its divestitures of the CNET Media Group to Red Ventures and the Simon & Schuster publishing business to Penguin Random House.*
  • China Mobile Ltd. in connection with a joint venture with Vodafone and Verizon Wireless for the development of mobile phone technologies.*
  • ViacomCBS in its acquisitions of the Garfield and U.S. Acres franchises, the Sparkler mobile and web applications, the VidCon technology conference, the AwesomenessTV and Chilevision film and television networks, and the SnowGlobe Music Festival.*
  • Warner Music Group in its acquisition of assets from SongKick.com, in its acquisition of Sodatone Inc. and in its equity investment in a company that performs audience data analytics.*
  • ViacomCBS and its subsidiary Paramount Pictures Corporation in Paramount Pictures Corporation's acquisition of DreamWorks LLC and in its distribution arrangements with DreamWorks Animation SKG, Inc.*
  • Discovery Communications LLC in connection with the separation of its UKTV joint venture with BBC Studios.*
  • Thomson Reuters Corporation in its acquisition of Capital Confirmation, Inc. and its acquisition of REDI Holdings.*
  • McGraw Hill Financial in connection with its sale of J.D. Power for $1.1 billion.*
  • J.D. Power & Associates in its acquisition of the Used Car Guide Business and associated data repositories of the National Automobile Dealers Association.*
  • WebMD Health Corp. in various corporate and transactional matters, including in its sale of Porex Corporation and in the acquisition by Internet Brands, a portfolio company of Kohlberg Kravis Roberts & Co. L.P.*
  • Banco Bradesco in its acquisition of BAC Florida Bank – 2021 Financial Services M&A Deal of the Year Award, The Deal.*
  • Intercontinental Exchange, Inc. in (i) the $11 billion acquisition of Ellie Mae, Inc. – 2021 Private Equity Deal of the Year Award, The Deal; (ii) the acquisition of SimpliFile;(iii) the acquisition of TMC Bonds; (iv) the sale of its “Interactive Data Managed Solutions” business; and (v) the sale of Trayport.*
  • Citibank N.A. in its sale of Citi’s Alternative Investor Services business, comprising of Hedge Fund Services and Private Equity Fund Services, to SS&C Technologies.*
  • Stone Point Capital in connection with the merger of Pierpont Securities LLC with Amherst Securities Group LP Helm Corporation in connection with the sale of Helm Bank SA to CorpBanca Colombia, a subsidiary of CorpBanca SA.*
  • Amundi Group in its acquisition, through subsidiary Amundi USA, Inc., of all of the outstanding shares of Smith Breeden Associates, Inc.*
  • Bakkt Holdings, LLC in its merger with SPAC VPC Impact Acquisition Holdings.*
  • NextEra and Compute North in connection with a cryptocurrency mining joint venture.*
  • Chipita S.A. on the sale of its business to Mondelēz International, Inc. for approximately $2 billion - CEE Legal Matters Deal of the Year Award 2021.*
  • Prairie Farms in connection with its acquisition of select assets and IP rights from Dean Foods.*
  • Sonic Corp. in its $2.3 billion sale to Inspire Brands.*
  • Tata Tea Ltd. in its acquisition of an equity interest in Glacéau, the maker of Vitaminwater.*
  • Shiseido Company Limited in the sale of its subsidiary, Zotos International Inc., to Henkel Corporation.*
  • Boston Scientific Corporation in (i) its acquisition of the cardiology business from Baylis Medical; (ii) the sale of the BTG Specialty Pharmaceuticals business to Stark International; (iii) the acquisition of the urology portfolio of American Medical Systems, Inc. from Endo International plc; (iv) the sale of its drug-eluting and bland embolizing bead business to Varian Medical Systems; and (v) the sale of its neurovascular business to Stryker Corporation InnovHeart SRL.
  • Quest Diagnostics Incorporated in connection with multiple acquisitions.*
  • LMA International N.V. in its acquisition of Wolfe Tory Medical, Inc. and its sale to Teleflex, Inc.*
  • Caris Life Sciences, Inc. in connection with the sale of its anatomic pathology business to Miraca Holdings.*
  • MeiraGTx holdings Plc in its acquisition of Emrys Bio.*
  • GENEWIZ Group, a leading global genomics service provider, in connection with being acquired by Brooks Automation.*
  • Fenway Sports Group LP in its acquisition of a controlling interest in the Pittsburgh Penguins of the National Hockey League.*
  • New England Sports Ventures (the parent company of the Boston Red Sox) in its acquisition of Liverpool Football Club of the English Premier League.*
  • Renaissance Sports & Entertainment, LLC in connection with its purchase of the Phoenix Coyotes franchise from the National Hockey League.*
  • Fenway Sports Group LP in connection with several trademark license and technology service agreements relating to its entry into a joint venture with Roush Racing, a leading race team whose drivers compete in NASCAR’s three premier series.*
  • Dow Chemical Company in (i) its $130 billion transaction with DuPont involving combination of the two companies and separating them into three publicly trading entities and the resulting $50 billion spin-off of Dow Inc.; (ii) the $5 billion split-off of the chlor-alkali and downstream derivatives business to Olin Corporation – 2016 M&A Deal of the Year Award, IFLR; (iii) its acquisition of the remaining interest in the Dow Corning’s silicones business from Corning Incorporated; (iv) the divestiture of its global polypropylene business to Braskem; (v) the $15.7 billion acquisition of Rohm and Haas; (vi) the $1.7 billion sale of Morton Salt; (vii) the sale of a diversified chemicals division to a leading global private investment firm; (viii) the sale of assets comprising EAA copolymers and ionomers business to SK Global Chemical Co.; and (ix) the sale of European extruded polystyrene foam business to Ravago SA.*
  • Celanese Corporation in the sale of Polyplastics Company, Ltd. to Daicel Corporation.*
  • LyondellBasell Industries N.V. in (i) its merger transaction with A. Schulman, Inc. for $2.25 billion; and (ii) the acquisition of a syngas plant and methanol production business from Linde AG.*
  • Lanxess in (i) the acquisition of the clean and disinfect businesses of Chemours; (ii) the acquisition of Emerald Kalama Chemical; and (iii) in the acquisition of the phosphorus chemicals business from Solvay Pharmaceuticals.*
  • Novartis AG in connection with its acquisition of the over-the-counter consumer medicines business of Bristol Myers Squibb Company; and in in its $3.9 billion acquisition of the French radiopharmaceutical company, Advanced Accelerator Applications – 2019 M&A Deal of the Year Award, IFLR.*
  • GlaxoSmithKline plc in its $5.1 billion acquisition of Tesaro.*
  • Sun Pharmaceutical Industries in connection with its purchase of Taro Pharmaceutical Industries.*
  • American Axle & Manufacturing Holdings, Inc. in connection with (i) its $1.6 billion cash and stock acquisition of Metaldyne Performance Group Inc.; and (ii) establishing a joint venture in China for the development of automotive technologies.*
  • Sumitomo Rubber Industries, Ltd. in the dissolution of its global alliance with The Goodyear Tire & Rubber Company Corning Incorporated (i) in its acquisition of 3M Company's global Fiber and Copper Connectivity Solutions Business;(ii) in its acquisition of Alliance Fiber Optic Products, Inc.; and (iii) in its acquisition of Axygen BioScience, Inc. Lafarge SA in the sale of its North American Gypsum business to an affiliate of Lone Star Funds.*
  • Daimler AG in its sale of the automotive and financial services business of the Chrysler Group to Cerberus Capital Management.*
  • Textron Inc. in the sale of its Tools and Test Business to Emerson Electric Co.*
  • Dover Corporation in its acquisition of JK Group S.p.A. from Wise SGR S.p.A. and Alcedo SGR S.p.A.*
  • Wausau Paper Corp. in its acquisition by Svenska Cellulosa Aktiebolaget.*
  • Ardagh Group in connection with (i) its combination of its Food & Specialty Metal Packaging business with Exal Corporation; and (ii) its purchase from Ball Corporation and Rexam PLC of certain metal beverage can manufacturing assets for an enterprise value of $3.42 billion.*
  • Raytheon Company in its merger of equals with United Technologies Corporation’s Aerospace Business – 2020 Deal of the Year Award and 2020 Energy & Industrials Deal of the Year Award, The Deal.*
  • JetBlue Airways in the sale of its live in-flight entertainment and connectivity business to Thales Avionics.*
  • B/E Aerospace in its $6.4 billion acquisition by Rockwell Collins.*
  • Aabar Investments PJSC in its acquisition of an equity interest in Virgin Galactic, an entity launched by the Virgin Group in 2004 to develop vehicles for space tourism.*
  • Ecopetrol in connection with its joint venture with Occidental Petroleum Corporation.*
  • OMERS Infrastructure Management in various transactions, including the acquisition of Navisun, the acquisition of the development business of First Solar, Inc. and sale of interests in Vento II wind portfolio.*

Capital Markets Transactions 

  • The initial public offering of Cytek Biosciences Gene Therapy, Gene Editing and Immunotherapy.*
  • The initial public offering of Caribou Biosciences, Inc.*
  • The initial public offering of Y-mAbs Therapeutics, Inc.*

*Handled prior to joining Ropes & Gray LLP

Areas of Practice